Hilar cholangiocarcinoma
Conditions
Interventions
Observation group of hilar cholangiocarcinoma:None
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Confirmed as hilar cholangiocarcinoma by postoperative pathological examination; 2.Underwent radical resection for hilar cholangiocarcinoma (R0 or R1 resection); 3.Complete preoperative baseline clinical data are available, including age, gender, comorbidities, laboratory examinations, etc. 4.Qualified preoperative contrast-enhanced abdominal CT or MRI imaging data are available (for radiomic analysis); 5.Complete postoperative paraffin-embedded pathological specimens and sections are available (for pathomic analysis and genomic detection); 6.Detailed perioperative data are available for the evaluation of "textbook outcome"; 7.Standardized postoperative follow-up data are available, including definitive records of overall survival and recurrence-free survival;
Exclusion criteria
Exclusion criteria: 1.Synchronous malignant tumors in other organs; 2.Patients with distant metastasis (M1) detected on preoperative imaging or intraoperatively; 3.Patients who received neoadjuvant chemotherapy, radiotherapy or immunotherapy preoperatively (to ensure that preoperative multimodal data truly reflect the initial status of the tumor); 4.Patients with missing or poor-quality key multimodal data (e.g., imaging, pathological specimens) that preclude analysis; 5.Patients lost to follow-up or with a follow-up duration of less than 12 months (unless death or recurrence occurred within 12 months);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;Recurrence-free survival; | — |
Countries
China
Contacts
Public ContactLiu Zhipeng
The First Affiliated Hospital of the Army Medical University of the People's Liberation Army of China
Outcome results
None listed